Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis

被引:5
作者
Chebotareva, N., V [1 ]
Gulyaev, S., V [1 ]
Androsova, T., V [1 ]
Popova, E. N. [1 ]
Gurova, D., V [1 ]
Novikov, P., I [1 ]
Milovanova, L. Y. [1 ]
Moiseev, S., V [1 ]
机构
[1] Sechenov Univ, Sechenov Moscow State Med Univ 1, Moscow, Russia
关键词
rheumatoid arthritis; kidney damage; chronic kidney disease; biological therapy; C-REACTIVE PROTEIN; AMYLOIDOSIS SECONDARY; RENAL PATHOLOGY; THERAPY; CYCLOPHOSPHAMIDE; INFLAMMATION; DYSFUNCTION; DECLINE;
D O I
10.26442/00403660.2020.05.000604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have shown a high risk of chronic kidney disease and associated cardiovascular complications in patients with rheumatoid arthritis (RA), which determines the prognosis. However, the prevalence of chronic kidney disease (CKD) in RA has not been established in the Russians. Aim. Study was to examine the prevalence, risk factors and histological variants of CKD in RA. Materials and methods. 180 patients with rheumatoid arthritis were observed in the Tareev clinic of nephrology, for the period from 2014 to 2019 years. Age, gender, duration of RA, drug therapy, ESR, CRP, DAS28, renal function, proteinuria, histological variants were analyzed. Of the common population risk factors for CKD arterial hypertension, weight index, serum lipids and glucose levels were also assessed. Results. The prevalence of CKD in RA was 19.7%. Age, presence and stage of arterial hypertension, an increase in body mass index, as well as high rates of disease activity - FSR, CRP, DAS28 score and duration of RA were risk factors of CKD in RA. Age, duration of the disease, stage of AH and hypercholesterolemia were risk factors in multifactorial regression analysis. Amyloidosis was the most common histologic pattern (50.0%), followed by chronic glomerulonephritis (30.4%) and tubulo-interstitial nephritis (19.6%). Among chronic glomerulonephritis mesangial glomerulonephritis was the most frequent. Renal amyloidosis was associated with a duration of RA, presence of systemic symptoms and CRP level. An isolated decrease in GFR of less than 60 ml/min was detected in 31 (36.0%) out of 86 patients. Conclusion. The risk factors for CKD in patients with RA are activity and duration of the disease In addition to common population factors. Amyloidosis was the most common histologic pattern associated with duration of RA and inflammatory proteins levels.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 40 条
  • [1] Batyushin MM, 2011, FAKTORY RISKA RAZVIT, P5
  • [2] RENAL FINDINGS IN RHEUMATOID-ARTHRITIS - CLINICAL ASPECTS OF 132 NECROPSIES
    BOERS, M
    CROONEN, AM
    DIJKMANS, BAC
    BREEDVELD, FC
    EULDERINK, F
    CATS, A
    WEENING, JJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (09) : 658 - 663
  • [3] Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis
    Daoussis, D.
    Panoulas, V. F.
    Antonopoulos, I.
    John, H.
    Toms, T. E.
    Wong, P.
    Nightingale, P.
    Douglas, K. M. J.
    Kitas, G. D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 517 - 521
  • [4] Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists
    Fernández-Nebro, A
    Tomero, E
    Ortiz-Santamaría, V
    Castro, MC
    Olivé, A
    de Haro, M
    García-Vicuña, R
    González-Mari, MV
    Laffón, A
    García-Vicuña, R
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 (05) : 552 - 556
  • [5] C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis
    Galarraga, B.
    Khan, F.
    Kumar, P.
    Pullar, T.
    Belch, J. J. F.
    [J]. RHEUMATOLOGY, 2008, 47 (12) : 1780 - 1784
  • [6] Góis Mário, 2017, Port J Nephrol Hypert, V31, P25
  • [7] Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83
  • [8] Short-Term Improvement of Endothelial Function in Rituximab-Treated Rheumatoid Arthritis Patients Refractory to Tumor Necrosis Factor α Blocker Therapy
    Gonzalez-Juanatey, Carlos
    Llorca, Javier
    Vazquez-Rodriguez, Tomas R.
    Diaz-Varela, Nicolas
    Garcia-Quiroga, Hermitas
    Gonzalez-Gay, Miguel A.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12): : 1821 - 1824
  • [9] Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides -: A followup report of tolerability and efficacy
    Gottenberg, JE
    Merle-Vincent, F
    Bentaberry, F
    Allanore, Y
    Berenbaum, F
    Fautrel, B
    Combe, B
    Durbach, A
    Sibilia, J
    Dougados, M
    Mariette, X
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (07): : 2019 - 2024
  • [10] RENAL BIOPSY FINDINGS AND CLINICOPATHOLOGICAL CORRELATIONS IN RHEUMATOID-ARTHRITIS
    HELIN, HJ
    KORPELA, MM
    MUSTONEN, JT
    PASTERNACK, AI
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (02): : 242 - 247